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Abstract 
Background: Component resolved allergen diagnosis allows for a precise evaluation of the sensitization profiles of 
patients sensitized to felines and canines. An accurate interpretation of these results allows better insight into the evo‑
lution of a given patients sensitizations, and allows for a more precise evaluation of their prognoses.
Methods: 70 patients (42 women and 28 men, aged 18–65, with the average of 35.5) with a positive feline or canine 
allergy diagnosis were included in the research group. 30 patients with a negative allergy diagnosis were included 
in the control group. The total IgE levels of all patients with allergies as well as their allergen‑specific IgE to feline and 
canine allergens were measured. Specific IgE levels to canine (Can f 1, Can f 2, Can f 3, Can f 5) and feline (Fel d 1, Fel d 
2, Fel d 4) allergen components were also measured with the use of the ImmunoCap method.
Results: Monosensitization for only one canine or feline component was found in 30% of patients. As predicted, 
the main feline allergen was Fel d 1, which sensitized as many as 93.9% of patients sensitized to felines. Among 65 
patients sensitized to at least one feline component, for 30 patients (46.2%) the only sensitizing feline component was 
Fel d 1. Only 19 patients in that group (63.3%) were not simultaneously sensitized to dogs and 11 (36.7%), the iso‑
lated sensitization to feline Fel d 1 notwithstanding, displayed concurrent sensitizations to one of the canine allergen 
components. Fel d 4 sensitized 49.2% of the research group.64.3% of patients sensitized to canine components had 
heightened levels of specific IgE to Can f 1. Monosensitization in that group occurred for 32.1% of the patients. Sensiti‑
zation to Can f 5 was observed among 52.4% of the patients.
Conclusions: Concurrent sensitizations to a few allergic components, not only cross‑reactive but also originating in 
different protein families, are a significant problem for patients sensitized to animals.
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Background
Allergy to fur animals is a significant clinical problem for 
patients visiting allergologists. Allergies to felines and 
canines are most familiar to science, mainly because of 
their high occurrence frequency, tied to common expo-
sure to allergens of these animals. In the USA alone, 
there are as many as 70 million dogs and 74.1 million 
cats living in households [1]. According to a 2012 study 
by TNS Poland about 48% of Poles own an animal. 
Among animal owners, in turn, 83% owns a dog, and 
44% a feline [2].
The frequency of the occurrence of animal allergies in 
both Europe and the US has been undeniably rising for 
the last few decades [3]. According to a large 2009 study 
by Heinzerling et al. for 3034 patients from 17 centres in 
14 European countries the average frequency of positive 
skin prick tests (SPT) with canine allergens was 27.2%, 
and 26.3% for feline allergens. The highest number of 
positive SPTs with these two types of allergens was noted 
in Odense in Denmark (56.0% for canines and 49.3% for 
felines), and the lowest in Vienna, Austria—16.1 and 
16.8% respectively. In Poland in the Łódź centre positive 
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SPTs were noted in 34.7% of cases and in 23.8% were pos-
itive to cat allergens [4].
An interesting study by Bjerg et  al. from 2015 ana-
lyzed levels of specific IgE to cat, dog and horse aller-
gens among 696 Swedish children aged 11–12, with 
the use of the ImmunoCap method. Elevated levels of 
specific IgE were found in 259 children (37.2%). Within 
that group, 51% showed symptoms of sensitization to all 
three allergens, 23% to two, and 25% to one of the aller-
gens [5].
Patients often inquire about the course of development 
of their allergies, their prognoses, as well as possibilities 
of a co-occurrence of allergies to other animals.
Latest developments in component resolved diag-
nosis can prove immensely helpful in answering these 
questions.
Component resolved diagnosis (CRD) is most defi-
nitely a breakthrough in allergology. It allows to conduct 
a detailed analysis of the patient’s sensitization profile, 
and is to ultimately lead to a complex and individualized 
treatment in each case.
Unfortunately, this method also has a few drawbacks. 
Most importantly, its high price and low availability (only 
few centres make use of it), as well as the fact that at its 
current stage CRD only allows to mark a few animal aller-
gic components making a negative result not identical to 
an allergy-excluding one [6], are all significant drawbacks 
of the method.
Not all known allergen components are available com-
mercially. Among feline allergens Fel d 1, Fel d 2, Fel d 4 
are available, as Can f 1, Can f 2, Can f 3, and Can f 5 are 
among canine allergen components. These can be used 
for a quantitive marking of IgE levels in blood serum 
using the highly sensitive, immune-fluorescent method, 
where antigens are tied in solid-phase (ImmunoCap). 
Another way of evaluating the levels of IgE antibodies 
against animal allergens is the semiquantitive microar-
ray ImmunoCap ISAC assay, which allows to mark the 
aforementioned 7 components of felines and canines, 
along with the total of 112 components from 51 allergen 
sources [7].
Testing specific IgE levels for selected allergen com-
ponents is used in academic work, but its application in 
practice continues to be limited. However, approaches 
to allergological diagnostics are undoubtedly developing 
in that direction. Allergies are now less conceived of in 
relation to the source of the allergen, and more in rela-
tion to a specific protein causing specific symptoms. This 
approach carries immense clinical implications, allowing 
to partially determine a natural development of the aller-
gic disease, and in the future will influence the choice of 
the most effective treatment.
Method and research material
Seventy patients (42 women and 28 men, aged 18–65, 
35.5 on average) with a positive history of pet allergy 
were selected from patients of the Department and Clinic 
of Allergology, Clinical Immunology and Internal Dis-
eases in Bydgoszcz. Patients treated for serious, chronic 
diseases and on medication that could influence the 
results of this study, were eliminated from the research 
group. Thirty patients (average age 37, aged 18–65) with 
negative allergy observation tests were included in the 
control group.
A detailed allergological interview was conducted for 
each patient, and a physical examination was conducted 
along with a skin prick test with extracts of common per-
ennial allergens, including feline and canine allergens, 
using the Allergopharma set.
Patients both from the control group and the research 
group had their blood samples taken to assess the total 
levels of IgE and allergen-specific IgE to feline and canine 
allergens. Levels of specific IgE to available allergen com-
ponents of canines (Can f 1, Can f 2, Can f 3, Can f 5) and 
felines (Fel d 1, Fel d 2, Fel d 4) were also determined.
All immunological determinations were performed 
with the use of the highly sensitive, immune-fluorescent 
ImmunoCap method (Thermo Fisher Scientific). The 
levels of IgE were evaluated as heightened when they 
exceeded 0.35 kU/l, in accordance with common practice 
in the field [5, 6].
Statistical analysis: Mann–Whitney and Kruskal–Wal-
lis test, with Dunn test post hoc analysis, where applica-
ble. Analyses were prepared using the R program, version 
3.3.1.
The study was approved by the local Bioethical Com-
mittee and was assigned a classification number: 
KB158/2014.
Results
In the research group feline allergen extract skin prick 
tests of 69 patients were positive, canine allergen skin 
prick tests tested positive for 34 patients. Heightened 
levels of total IgE (exceeding 100  kU/l) were found in 
55 patients (78.6%). Heightened levels of specific IgE (in 
accordance with the commonly accepted threshold of 
0.35 kU/l) against dog allergen extract were found in 56 
patients, and in 66 patients against cat allergen extract. 
Levels of IgE specific for dogs and felines exceeding 
0.7  kU/l were found in 46 and 63 patients respectively. 
Heightened levels (≥0.35 kU/l) of specific IgE to at least 
one of the allergen components of felines were found 
in 65 patients, and against at least 1 allergic component 
of canines in 42 patients. Out of the research group, 3 
patients did not have heightened levels of specific IgE to 
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any canine and feline components, and for 21 (30%) of 
patients a monosensitization to only 1 canine or feline 
component was noted.
Table 1 below presents the characteristics of the study 
population, including the frequency of sensitizations to 
animal allergen components in the research group.
Table  2 presents the concentration of IgE, both total 
and specific, in female and male patients. The param-
eters, that are gender dependent are the concentration of 
IgE specific to Fel d 1 (p = 0.042) and Can f 1 (p = 0.031).
We also evaluated the concentration of IgE depend-
ing on age of the subjects. The analysis was limited by 
the size of the population, therefor we analyzed 3 age 
groups—Group A, 22 patients, age <25 years old; Group 
B, 26 patients age 25–40; Group C, 22 patients >40. We 
found that the concentration of IgE specific to cat aller-
gen extract was age dependent (p = 0.032), with higher 
values in patients  >40 than in patients  <25  years old. 
Concentration of total IgE, IgE specific to dog allergen 
extract and to all evaluated allergen components were 
not age dependent.
Both intra- and inter-specie co-occurrence of sensitiza-
tions to particular animal allergen components are here 
very important. Figure 1 illustrates the co-occurrence of 
sensitizations to different canine allergen components, 
and Fig. 2 to different feline allergen components. In both 
cases IgE levels exceeding 0.35  kU/ml were taken into 
consideration.
What draws attention here is the high frequency of 
allergies to both canine and feline allergen components 
in individual patients. It is worth noting that out of 32 
patients sensitized to Fel d 4, as many as 28 (87.5%) had 
signs of sensitization to Fel d 1.
Fewest patients (16) had elevated levels of IgE to the Fel 
d 2 component. Within that group 13 (81.3%) had height-
ened IgE levels against Fel d 1, and 13 (81.3%) against Fel 
d 4.
Similar correlations can be found in the group of 
patients with sensitization to canines. The highest fre-
quency of heightened IgE levels was noted for Can f 1 
and Can f 5, main canine allergen components. Notably, 
heightened levels of specific IgE to Can f 2 were found in 
10 patients, among which 9 had also sensitization to Can 
f 1, 7 patients in that group displayed sensitization also 
to Can f 3, and 6 out of these 10 patients were allergic to 
Can f 5.
Only 1 patient had an isolated sensitization to the Can 
f 2 allergen component. It is worth noting that as many as 
12 (75%) out of 16 patients with heighted levels of specific 
IgE to Can f 3 (canine albumin) also sensitized to Can f 1.
Table 1 Characteristics of the study population, including the frequency of sensitization to animal allergen components 
in the research group
Features Study group, n = 70
Gender Male‑28 Female‑42
Age (mean, min. and max. value) 35.5; 18–65
33.3; 19–65 37; 18–65
Concentration of total IgE (mean, min. and max. value) in kU/l 806.3; 7.44–5375
502.4; 7.44–5000 1008.9; 13–5375
Canine allergen components: number of patients with allergen-specific IgE levels exceeding 0.35 kU/l
Can f 1 (lipocalin) 28 (40% of the study group)
7 (25% of male) 21 (50% of female)
Can f 2 (lipocalin) 10 (14.3% of the study group)
1 (3.6% of male) 9 (21.4% of female)
Can f 3 (albumin) 16 (22.9% of the study group)
6 (21.4% of male) 10 (23.8% of female)
Can f 5 (prostate gland ‑ kallikrein) 22 (31.4% of the study group)
7 (25% of male) 16 (38.1% of female)
Feline allergen components: number of patients with allergen-specific IgE levels exceeding 0.35 kU/l
Fel d 1 (secretoglobin, a uteroglobin‑like protein) 61 (87.1% of the study group)
27 (96.4% of male) 35 (83.3% of female)
Fel d 2 (albumin) 16 (22.9% of the study group)
6 (21% of male) 10 (23.8% of female)
Fel d 4 (lipocalin) 32 (45.7% of the study group)
10 (35.7% of male) 22 (52.4% of female)
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A significant number of patients had co-occurring sen-
sitizations to more canine components. As many as 6 had 
also sensitization to all 4 canine allergen components, 
sensitizations to 3 canine allergen components were 
found in 3 patients, sensitization to 2 canine compo-
nents in 11 patients, and sensitization to one component 
in 22 patients out of 42 who had specific IgE to canine 
components.
Correlations between levels of particular canine and 
feline allergens in the research group were also studied. 
The findings show that there is a positive correlation 
between levels of canine allergen components (with the 
correlation ratio min. 0.7), but such a correlation was not 
noted for feline allergen components.
The correlation between the levels of each allergen 
component is presented in Table 3.
An analysis of co-occurrence of sensitizations to each 
canine and feline allergen components is also highly 
important. Table 4 presents the number of patients sensi-
tized to canine and feline cross-reacting allergens.
Interestingly, out of 10 patients with heightened levels 
of specific IgE to Can f 2, as many as 9 simultaneously 
had heightened levels of specific IgE to Fel d 4. Among 
the 16 patients sensitized to Fel d 2 and the 16 sensitized 
to Can f 3, as many as 15 (93.8%) had IgE antibodies 
reacting both with feline and canine albumin. No correla-
tion between levels of IgE antibodies specific to albumin 
and lipocalin of canine and feline was noted, as illustrated 
on Graphs 1 and 2.
An analysis of the occurrence of an isolated sensitiza-
tion to allergen components not commonly accepted as 
the reason behind cross-reactions also proves interesting. 
The main cat allergen, Fel d 1, a uteroglobin-like protein 
from the secretoglobin family, is an exception among 
mammal allergens, because in the majority of cases the 
main allergen is lipocalin. In our research group of 70 
patients, 61 (87.1%) had heightened levels of specific IgE 
to Fel d 1. In the same group, 30 patients had elevated lev-
els of IgE against Fel d 1, but with no specific antibodies 
against Fel d 2 and Fel d 4. Within that group 19 (63.3%) 
had an isolated sensitization to Fel d 1 among the exam-
ined animal allergen components. Curiously, 11 patients 
had heightened levels of IgE against Fel d 1, no specific 
antibodies against Fel d 2 (albumin) or Fel d 4 (lipocalin), 
but at the same time were sensitized to canine allergens.
Among canine allergen components Can f 5, a prostatic 
kallikrein, an arginine esterase, is of particular interest. 
In our research group 23 (32.9%) patients had elevated 
levels of specific IgE against Can f 5, 9 patients were 
sensitized only to Can f 5 out of all canine allergens, but 
simultaneously had symptoms of sensitization to feline 
allergen components; one patient had an isolated Can f 5 
sensitization (only one among the canine and feline com-
ponents under examination).
Table 2 Concentration of  IgE in  male and  female (Mann–Whitney test, results are considered statistically significant 
when p < 0.05)
Statistically significant results are written in italics
Feature Gender N Mean value SD Median Min Max p
Total IgE Female 42 1008.92 1565.08 322.65 13 5375 p = 0.286
Male 28 502.35 932.87 263 7.44 5000
IgE specific to canine Female 42 16.91 33.28 1.45 0 100 p = 0.302
Male 28 5.79 18.73 1.2 0 100
rCan f 1 Female 42 14.55 29.84 0.34 0 100 p = 0.031
Male 28 3.6 15.94 0 0 84.6
rCan f 2 Female 42 8.39 23.81 0 0 100 p = 0.157
Male 28 3.11 16.4 0 0 86.8
nCan f 3 Female 42 11.5 28.08 0.02 0 100 p = 0.077
Male 28 1.85 5.72 0 0 28.4
rCan f 5 Female 42 8.87 24.5 0.11 0 100 p = 0.165
Male 28 1.32 5.75 0.04 0 30.6
IgE specific to feline Female 42 15.11 24.1 3.58 0 100 p = 0.644
Male 28 17.21 24.66 3.67 0.01 100
rFel d 1 Female 42 11.83 22.98 3.62 0 100 p = 0.042
Male 28 18.93 24.74 6.47 0 100
nFel d 2 Female 42 7.81 22.46 0 0 100 p = 0.486
Male 28 4.98 18.98 0 0 98.5
rFel d 4 Female 42 4.84 8.13 0.62 0 37.2 p = 0.089
Male 28 3.46 8.96 0.03 0 42.1
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In the control group all participants had negative skin 
prick tests to animal allergens. No heightened levels of 
specific IgE to feline and canine allergens, or specific IgE 
to the canine and feline allergen components were found.
Discussion
To our knowledge only few studies have addressed the 
clinical relevance of component resolved diagnosis in 
dog and cat allergy. The present study is focusing on the 
frequency of hypersensitivity to commercially available 
cat and dog allergen components in adult patients with 
symptoms of allergy to pets.
Fel d 1, thee main feline allergen, caused sensitizations 
in 93.9% of patients with sensitization to feline allergen 
components, from which group monosensitization was 
found in 30 (49.2%). A study by Bjerg et  al. [5] found 
sensitization to the Fel d 1 component in 83.7% of its 
research group, which comprised of 208 children aged 
11–12 sensitized to felines. In that group monosensitiza-
tion was found in 67.8% of patients [5].
In the research group the second most frequent feline 
allergen was Fel d 4. Heightened levels of specific IgE for 
this feline lipocalin were found in 49.2% of patients. In 
Fig. 1 Co‑occurrence of sensitizations to different canine allergen components (number of patients)
Fig. 2 Co‑occurrence of sensitizations to different feline allergen 
components (number of patients)
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the study by Bjerg et al. mentioned above, sensitization to 
Fel d 4 was found in 31.3% of the research group.
It is worth to emphasize, that in our population of adult 
patients the prevalence of polisensitization was higher 
than in the study population of Bjerg et al. It is consistent 
with findings of Asarnoj et al who found, that co sensiti-
zation to cat and dog allergen molecules becomes more 
common when patients are getting older. In their study 
children were examined during three time points (at 4, 8 
and 16 years), and the level of IgE directed against aller-
gen components were measured using microarray tech-
nology ImmunoCap ISAC. IgE reactivity to any of the 
3 cat allergen molecules tested increased from 9.2% at 
4 years up to 21.8% 16 years [8].
Results of The National Health and Nutrition Exami-
nation Survey (NHANES) 2005–2006 prove, that, in 
the USA population, production of IgE is dependent on 
sociodemographic factors, including gender and age. In 
NHANES 2005–2006 males seem more likely to have 
positive sIgE tests as well as elevated levels of sIgEs than 
females. What is more, inhalant allergen-specific IgEs 
peaked in childhood and early adulthood, declining in 
older age. According to authors it may reflect changes in 
the immune system that accompany aging [9].
In the present study it is worth to emphasize, that 
although there is a difference in mean value of total 
IgE in female and male, it is not statistically significant 
(Table 2). The parameters that are gender dependent are 
the concentration of IgE specific to Fel d 1 (p =  0.042), 
with higher values in male, and Can f 1 (p = 0.031), with 
higher values in female. In our study concentration of 
IgE specific to cat allergen extract was age dependent 
(p  =  0.032), with higher values in patients  >40 than in 
patients <25 years old. In case of evaluated allergen com-
ponents the concentrations of IgE were not age depend-
ent, although we feel that further research, on large 
population of adult patients, is necessary.
Among canine allergens, sensitization to the Can f 1 
component was the most frequent—heightened levels of 
IgE were found in 64.3% of patients sensitized to canine 
allergen components. Within that group monosensiti-
zation was found in 9 patients (32.1%). Sensitization to 
Can f 5 was found in 52.4% of patients. In the study by 
Bjerg et  al. [5] out of 218 patients (39%) 85 were found 
to be sensitized to Can f 1, and 102 (46.8%) to Can f 5. 
Sensitization to Can f 2 occurred as monosensitization 
extremely rarely, which was confirmed by our findings (1 
patient in the research group). The difference in amount 
of patients sensitized to Can f 1 and Can f 5 in our popu-
lation may be gathered with multiple factors, including 
age of the population, different pattern of sensitization or 
different methodology of the research [5].
Assessing levels of specific IgE to canine and feline 
allergen components can be helpful in making progno-
ses about patients who experience allergy reactions after 
contact with those animals. Some animal allergy compo-
nents can cross-react both intra- and inter-species.
Information about a specific canine or feline protein 
which causes the sensitization carries important clinical 
implications. Relying on knowledge of the component 
source of the sensitization, theoretically, a potential risk 
of a cross-allergy, the potential a-typicality of the allergy, 
or even risks of infertility can be determined. In reality, 
however, things are, unfortunately, different. The above 
study points out the importance of allergy co-occurrence 
as a medical problem, not only among lipocalins or albu-
mins, but also as a co-occurrence of an allergy to proteins 
belonging to different families. Undoubtedly this factor 
contributed to an obscuring of the correct clinical view 
of a case.
It seems that among patients sensitized to felines, with 
heightened levels of specific IgE to the main allergen Fel 
d 1, but who do not have specific IgE to other feline com-
ponents, the risk of a cross-allergy to other fur animals 
is low, and is mainly related to allergies to rabbits. How-
ever, the above results indicate that among 65 patients 
sensitized to at least one feline component, for 30 (46.2%) 
it is the only sensitizing feline component, and within 
that group only 19 (63.3%) patients are not simultane-
ously sensitized to canines, with 11 (36.7%), despite an 
Table 3 The correlation between the levels of each allergen component in the research group
rCan f 1 rCan f 2 nCan f 3 rCan f 5 rFel d 1 nFel d 2 rFel d 4
rCan f 1 1 0.90 0.77 0.71 −0.01 0.31 0.29
rCan f 2 1 0.77 0.82 −0.15 0.25 0.25
nCan f 3 1 0.75 −0.09 0.67 0.18
rCan f 5 1 −0.16 0.21 0.25
rFel d 1 1 0.11 0.44
nFel d 2 1 0.18
rFel d 4 1
Page 7 of 9Ukleja‑Sokołowska et al. Allergy Asthma Clin Immunol  (2016) 12:61 
isolated feline Fel d 1 sensitization, having symptoms of 
a concurrent sensitization to some of the canine allergen 
components.
One of the explanations of this phenomenon may come 
from an interesting research by Reininger et al. It was the 
first report demonstrating the presence of an Fel d 1-like 
allergen in dog dander extracts. It was found that in 25% 
of Fel d 1-reactive cat-allergic patients (n  =  36), more 
than 50% inhibition of IgE reactivity to dog allergens was 
achieved with recombinant Fel d 1 [10].
What is more, it seems that the isolated allergy to 
canine kallikrein is extremely rare. In our research group 
42 patients had a sensitization to at least one canine com-
ponent, 23 of them displayed symptoms of sensitization 
to Can f 5, and 9 out of these, in turn, out of all canine 
allergen components had an isolated sensitization only 
to Can f 5. Only one patient did not have a simultaneous 
sensitization to any of the feline allergen components.
An important observation seems, that there is a cor-
relation between concentration of specific IgE to canine 
allergen components, but no such correlation is being 
observed in case of feline allergen components (Table 3). 
This phenomenon is not entirely understood. We know, 
that Can f 1 and Can f 2 have common epitopes and that 
most of the patients allergic to Can f 2 are co sensitized to 
Can f 1 [11, 12].
It remains partially unclear why in patients sensitized 
to fur animals the frequency of co-occurring allergies to a 
few components is high. Characteristically, this co-occur-
rence is related to components from different protein 
families. The high frequency of a co-occurring sensitiza-
tion to various allergen components that we found in our 
research group confirms previous findings on this subject.
In a study by Liccardi et al. 900 people, 1/3 out of which 
had a sensitization to canines and felines and 1/3 were a 
non-atopic control group, the authors found that in the 
group of 300 people with sensitization to canines and 
felines there were significantly more people sensitized 
also to other fur animals in comparison to the other 300 
patients sensitized to other allergens. Moreover, it was 
found that lack of immediate contact with a given animal 
(at home or through a hobby) does not exclude an allergy, 
indicating either a cross-reaction, or an ontogenetic pro-
pensity to an allergy to animal hair [13].
A 2015 study by Liccardi et  al. conducted a similar 
analysis, relying on molecular diagnostics. They retro-
spectively analyzed results of an ISAC test from Allergy 
Unit, Fondazione Salvatore Maugeri, compiled in the 
course of 2  years. They divided patients into exactly 
the same groups as in the study described above (552 
patients with a sensitization to canines or felines, 315 
sensitized to inhalatory allergens different than canine or 
feline, and 189 patients with negative ISAC test results). 
They found that 42.9% of patients with sensitization to 
canines or felines had heightened levels of IgE to Equ c 
1 (equine lipocalin) and Mus m 1 (mouse lipocalin). In 
other patient groups no heightened levels of specific IgE 
to Equ c 1 and Mus m 1 were found [14].
In our research group only 30% of the patients dis-
played monosensitization to 1 canine or feline compo-
nent. Our results are also tangent with the latest study 
on the subject conducted by Uriarte et al. [12] which ana-
lyzed 159 patients with sensitization to animals. Only 5% 
of patients in that group were found to have monosensi-
tization to a single allergen component; 86% of patients 
with sensitization to Fel d 4 were also sensitized to Fel d 
1 [15]. In our study sensitization to Fel d 1 was found in 
87.5% of patients sensitized to Fel d 4. Out of 10 patients 
found to have heightened levels of specific IgE to Can f 2, 
9 also displayed heightened levels of specific IgE to Fel d 
4.
There are a few drawbacks to this study. Although it 
was generally well conducted, with wide range of diag-
nostics, including skin prick tests and serum concentra-
tion of total IgE, specific IgE and IgE directed against 
currently available cat and dog allergen components 
(ImmunoCap), the results are based on only 70 adult 
patients. This study would benefit from extending the 
population, but it was limited by relatively high cost of 
allergen components in ImmunoCap, which were funded 
with an internal grant, number SLD-4/WL/2015 (Ludwik 
Rydygier Collegium Medicum in Bydgoszcz, NCU).
Conclusion
Component resolved allergen diagnosis allows to 
improve diagnostics of sensitizations to animals. The pri-
mary drawbacks of this method are related to the high 
costs of marking IgE, as well as to the limited availability 























Lipocalin Fel d 4 32 Can f 1 27 Fel d 4 and Can f 1 20
Lipocalin Fel d 4 32 Can f 2 10 Fel d 4 and Can f 2 9
Albumin Fel d 2 16 Can f 3 16 Fel d 2 and Can f 3 15
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of particular allergen components. However, for particu-
lar patients an evaluation based on a detailed profile of 
sensitization to canines or felines and its correct inter-
pretation may aid the process of determining the source 
of a-typical symptoms, and thus facilitate an accurate 
prognosis of the development of an animal fur allergy.
A highly relevant issue for most patients is the co-
occurrence of sensitizations to a selection of allergen 
components, not only cross-reactive but also originating 
in different protein families. Monosensitivity to a specific 
allergen component occurs relatively rarely—our study 
noted it in 30% of tested patients.
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